The Connect Trial: Connecting Hospital Patients to Alcohol Care
1 other identifier
interventional
60
1 country
1
Brief Summary
The main objective of this pilot study is to assess feasibility of conducting a definitive RCT with concealed allocation, blinded outcome assessment and a 1:1 parallel group design of A) an invitation to meet an AUD therapist for up to 10 treatment sessions at the hospital in up to 6 months (intervention) compared to B) guidance on how to seek alcohol care in an AUD treatment centre in the community, outside of the hospital (control).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2026
CompletedStudy Start
First participant enrolled
March 10, 2026
CompletedFirst Posted
Study publicly available on registry
March 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2031
March 24, 2026
March 1, 2026
1.5 years
March 9, 2026
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Recruitment
\>50% of eligible individuals invited to the study give written informed consent
6 months
Retention
\>50% individuals recruited and randomized to the intervention, will attend to the intervention of seing the AUD therapist at least once
6 months
Completion
\>50% of all randomized study participants complete the follow-up interview and blood sample
6 months
Secondary Outcomes (12)
AUD treatment engagement after 6 and 12 months
12 months
Mortality after 6 and 12 months
12 months
Change in drinks (containing 12 g ethanol) per last 30 days from baseline till 6 months after inclusion
6 months
Proportion with abstinence or light drinking (<10 drinks/week) last 30 days
6 months
Change in blood phosphatidyl ethanol level from baseline to 6 months after inclusion
6 months
- +7 more secondary outcomes
Study Arms (2)
Control group
ACTIVE COMPARATORParticipants randomised as controls will be offered a leaflet informing about different possibilities for alcohol misuse treatments and guidance on how to approach them (may include referral or help with doing an appointment, if possible according to the specific treatment center) in the catchment area of SUH Køge and Roskilde.
Intervention group
EXPERIMENTALParticipants will be offered an AUD treatment session at the hospital the same or next day as they are enrolled in the study with an outreach alcohol therapist from a local AUD treatment facility. The alcohol therapist will be trained in motivational interviewing and cognitive behavioural therapy for AUD. The session will last for 20 to 60 minutes and can take place either at the department where the patient is admitted or elsewhere to ensure confidentiality. Up to 10 sessions at the hospital during 6 months after the baseline visit can be offered and after that, the participant can continue to meet with the same therapist in the community alcohol treatment facility. The participant will also be informed about other options for specialised alcohol treatment, group therapy, peer support and self-help groups.
Interventions
Participants will be offered an AUD treatment session at the hospital the same or next day as they are enrolled in the study with an outreach alcohol therapist from a local AUD treatment facility. The alcohol therapist will be trained in motivational interviewing and cognitive behavioural therapy for AUD. The session will aim to motivate patients to reduce their alcohol consumption and set goals for AUD treatment. The alcohol therapist can recommend a medical therapy to support alcohol reduction or abstinence - this prescription will be undertaken by a hepatologist from the Department of Medicine and may be continued after discharge by patients´ general practitioner or physicians at the AUD treatment facility. Up to 10 sessions of up to 60 minutes of duration at the hospital during 6 months after the baseline visit can be offered and after that, the participant can continue to meet with the same therapist in the community.
Participants randomised as controls will be offered a leaflet informing about different possibilities for alcohol misuse treatments and guidance on how to approach them (may include referral or help with doing an appointment, if possible according to the specific treatment center) in the catchment area of SUH Køge and Roskilde
Eligibility Criteria
You may qualify if:
- Hospitalised or seen in an outpatient clinic at SUH Køge
- Full-filling international classification of disease version 10: F102: alcohol dependence or F101: harmful alcohol use
- Informed written consent
- Being able to meet the AUD therapist in connection with a hospital visit with a health condition wholly or partly attributable to alcohol
You may not qualify if:
- Ongoing specialized treatment for AUD
- Not speaking Danish
- Not living in the catchment area of Zealand University hospital
- Age \< 18 years
- Enrolled in the Zealand alcohol-related liver disease cohort study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zealand University Hospital, Department of Medicine
Køge, 4600, Denmark
Related Publications (2)
Schwarz AS, Nielsen B, Sogaard J, Sogaard Nielsen A. Making a bridge between general hospital and specialised community-based treatment for alcohol use disorder-A pragmatic randomised controlled trial. Drug Alcohol Depend. 2019 Mar 1;196:51-56. doi: 10.1016/j.drugalcdep.2018.12.017. Epub 2019 Jan 17.
PMID: 30665152BACKGROUNDIncze MA, Kelley AT, James H, Nolan S, Stofko A, Fordham C, Gordon AJ. Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and Taxonomy. J Gen Intern Med. 2024 Apr;39(5):837-846. doi: 10.1007/s11606-024-08670-5. Epub 2024 Feb 27.
PMID: 38413539BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gro Askgaard
Sjaellands Universitetshospital Køge, Medicinsk Afdeling
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- allocation concealment
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
March 9, 2026
First Posted
March 19, 2026
Study Start
March 10, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2031
Last Updated
March 24, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share